Functional analysis of regulatory single-nucleotide polymorphisms

Current Opinion in Lipidology

Volumn 18, Issue 2, 2007, Pages 194-198

  Pampín, Sandra ^a   Rodríguez Rey, José C ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Common diseases; Gene expression analysis; Promoter; Regulatory SNPs; SNPs

Indexed keywords

DNA; LUCIFERASE; RNA; TRANSCRIPTION FACTOR;

CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; DNA DETERMINATION; DNA PROTEIN COMPLEX; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LYMPHOBLASTOID CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LDL;

EID: 33947153023     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3280145093     Document Type: Review

References (37)

1. Villeger L, Abifadel M, Allard D, et al. TheUMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 2002; 20:81-87.
2. Lander ES. Genomics: launching a revolution in medicine. J Law Med Ethics 2000; 28:3-14.
3. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-510.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8:1-21.
5. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26:76-80.
6. King MC, Wilson AC. Evolution at two levels in humans and chimpanzees. Science 1975; 188:107-116.
7. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002; 19:1991-2004.
8. Dedoussis GV, Pitsavos C, Kelberman D, et al. FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia. Clin Genet 2003; 64:414-419.
9. Francova H, Trbusek M, Zapletalova P, Kuhrova V. New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis. J Inherit Metab Dis 2004; 27:523-528.
10. Koivisto UM, Palvimo JJ, Janne OA, Kontula K. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A 1994; 91:10526-10530.
11. Mozas P, Galetto R, Albajar M, et al. A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. J Lipid Res 2002; 43:13-18.
12. Sun XM, Neuwirth C, Wade DP, et al. A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Hum Mol Genet 1995; 4:2125-2129.
13. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G. Locus control regions. Blood 2002; 100:3077-3086.
14. Dang Q, Walker D, Taylor S, et al. Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus. J Biol Chem 1995; 270:22577-22585.
15. Kuppuswamy MN, Hoffmann JW, Kasper CK, et al. Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci U S A 1991; 88:1143-1147.
16. Singer-Sam J, Chapman V, LeBon JM, Riggs AD. Parental imprinting studied by allele-specific primer extension after PCR: paternal X chromosome-linked genes are transcribed prior to preferential paternal X chromosome inactivation. Proc Natl Acad Sci U S A 1992; 89:10469-10473.
17. Cheung VG, Conlin LK, Weber TM, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33:422-425.
18. Norton N, Williams NM, Williams HJ, et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002; 110:471-478.
19. Lo HS, Wang Z, Hu Y, et al. Allelic variation in gene expression is common in the human genome. Genome Res 2003; 13:1855-1862.
20. Morley M, Molony CM, Weber TM, et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430:743-747.
21. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003; 33:469-475.
22. De Gobbi M, Viprakasit V, Hughes JR, et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 2006; 312:1215-1217. •• This is a fine example of the combination of chromatin immunoprecipitation and classical functional analysis of gene expression.
23. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2:1044-1051.
24. de Wet JR, Wood KV, DeLuca M, et al. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7:725-737.
25. Graham FL, van der Eb AJ. Transformation of rat cells by DNA of human adenovirus 5. Virology 1973; 54:536-539.
26. McCutchan JH, Pagano JS. Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst 1968; 41:351-357.
27. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1982; 1:841-845.
28. Zimmermann U. Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta 1982; 694:227-277.
29. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987; 84:7413-7417.
30. Sherf B, Navarro S, Hannah R, Wood K. Dual-Luciferase™ reporter assay: an advanced co-reporter technology integrating firefly and renilla luciferase assays. Promega Notes 1996; (57):2-9.
31. Matthews JC, Hori K, Cormier MJ. Purification and properties of Renilla reniformis luciferase. Biochemistry 1977; 16:85-91.
32. Yang WS, Nevin DN, Iwasaki L, et al. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res 1996; 37:2627-2637.
33. Hoogendoorn B, Coleman SL, Guy CA, et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet 2003; 12:2249-2254.
34. Buckland PR, Hoogendoorn B, Guy CA, et al. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta 2004; 1690:238-249.
35. Buckland PR, Hoogendoorn B, Coleman SL, et al. Strong bias in the location of functional promoter polymorphisms. Hum Mutat 2005; 26:214-223. • This is very important when designing future searches of regulatory polymorphisms.
36. Buckland PR. The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim Biophys Acta 2006; 1762:17-28. •• This is a very good review on the basics of regulatory polymorphisms.
37. Mottagui-Tabar S, Faghihi MA, Mizuno Y, et al. Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genomics 2005; 6:18. • This describes a simple, but efficient method for the bulk analysis of rSNPs.